Study identifies immune profile of people with severe COVID-19

A team of researchers at Georgetown University Medical Center, USA, investigated how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affects

Read more

Live attenuated SARS-CoV-2 vaccine candidate shows protective efficacy in vivo

With the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Wuhan, China, the coronavirus disease 2019 (COVID-19) pandemic

Read more

Elevated Activin A and FLRG levels correlate with worst outcomes in severe COVID-19

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes a "cytokine storm" in hospitalized and ICU patients. Studies have shown

Read more

Second dose of Pfizer-BioNTech COVID-19 vaccine may not benefit previously infected individuals

Researchers at the NYU Grossman School of Medicine have shown that a second dose of the Pfizer-BioNTech BNT162b2 vaccine may

Read more

A precursor to remdesivir shows therapeutic potential for COVID-19

In the pursuit of effective antiviral drugs to counter the current coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute

Read more